Mary Tolan Overview
- Investor Type
-
Angel
- Investments
-
3
- Portfolio
-
2
- Exits
-
1

Mary Tolan General Information
Description
Ms. Mary Tolan is a Co-Founder and serves as Managing Partner at Chicago Pacific Founders. She serves as Board Member at Tredence. She serves as Board Member at Peel Therapeutics. She also serves as Advisor at Super.tech. She serves as Board Member at Atrio Health Plans. She serves as Board Member at Healthbox. She was also the founder of Accretive Health, a leading provider of comprehensive end-to-end healthcare revenue-cycle management services and population health management services infrastructure. Mary served as Accretive Health's Chief Executive Officer from November of 2003 to April of 2013 and served as Board Chair until November 2013. During that period Mary built Accretive Health from an idea into a billion dollar enterprise over a nine year period by building and leading a team of seasoned industry professionals focused on revolutionizing patient access and revenue-cycle processes for health- care providers. Mary led the IPO of Accretive Health in 2010 earning it a $1.2 billion market capitalization. Previously, Mary was a Group Chief Executive at Accenture, the $64 billion market cap global management consulting, technology services, and outsourcing company. At Accenture she was the Group Chief Executive of a $2.3 billion global operating group. Mary also played a leadership role in taking Accenture public in 2001, one of that year's largest offerings on the New York Stock Exchange. Mary's accomplishments as a business leader have earned her many recognitions and awards including being named the EY Entrepreneur Of The Year 2010 National Winner in the Services Category and leading Accretive Health to be named the Illinois Venture Capital Association's Company of the Year in 2011. Mary serves on the Boards of trustees for the University of Chicago and Loyola University. She received a Bachelor of Business Administration degree from Loyola University and an MBA from the University of Chicago.
Contact Information
- 980 North Michigan Avenue
- Suite 1998
- Chicago, IL 60611
- United States
Mary Tolan Investments (3)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
BioIntellisense | 28-Jul-2021 | Early Stage VC | 0000 | Monitoring Equipment | Generating Revenue | 0000 00000 |
00000.0000 | 15-Jun-2020 | 00000 00000 | 00000 | Business/Productivity Software | Generating Revenue | 0000 00000 |
0000000 000000 | 02-Apr-2015 | 00000 00000 | 000 | Other Healthcare Technology Systems | Generating Revenue | 0000 00000 |
Mary Tolan Exits (1)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
00000.0000 | 10-May-2022 | 000000000000000000 |
Mary Tolan Investments by Industry, Year, and Region
Mary Tolan Team (1)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Mary Tolan | Angel Investor | 00 | 0 | 0 | Chicago, IL |
Mary Tolan Co-Investors (11)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Fresenius Medical Care | 1 | 0 |
![]() |
![]() |
|
Pendrell | 0 | 0 |
![]() |
![]() |
|
Philips Ventures | 0 | 0 |
![]() |
![]() |
|
Royal Philips Electronics (Restoratives and Impression Portfolios) | 0 | 0 |
![]() |
![]() |
|
TT Capital Partners | 0 | 0 |
![]() |
![]() |